علاج التهاب المعدة الضموري الحؤولي المناعي الذاتي مع عدوى هيليكوباكتر بيلوري النشطة

DOI: 10.14309/ajg.0000000000002968

Given the implications of potentially undiagnosed H. pylori infection for cancer risk and exacerbating nutritional deficiencies (e.g., iron deficiency), H. pylori testing and treatment in all patients diagnosed with AIG are recommended.

Of the recommended and suggested options for treatment-naive patients, only optimized BQT is suitable for patients with a true penicillin allergy.

In treatment-naive patients with H. pylori infection, optimized BQT is recommended as a first-line treatment option (strong recommendation; moderate quality evidence).

All patients who are treated for H. pylori infection should undergo a test of cure with an appropriately conducted urea breath test, fecal antigen test, or biopsy-based test at least 4 weeks after completion of therapy.